- Home
- WES vs ICLR Comparison
WES vs ICLR Comparison
Compare WES & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WES
- ICLR
- Stock Information
- Founded
- WES 2007
- ICLR 1990
- Country
- WES United States
- ICLR Ireland
- Employees
- WES N/A
- ICLR N/A
- Industry
- WES Natural Gas Distribution
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- WES Utilities
- ICLR Health Care
- Exchange
- WES Nasdaq
- ICLR Nasdaq
- Market Cap
- WES 14.9B
- ICLR 17.2B
- IPO Year
- WES 2008
- ICLR 1998
- Fundamental
- Price
- WES $41.59
- ICLR $202.19
- Analyst Decision
- WES Hold
- ICLR Strong Buy
- Analyst Count
- WES 9
- ICLR 12
- Target Price
- WES $38.00
- ICLR $284.82
- AVG Volume (30 Days)
- WES 1.1M
- ICLR 927.2K
- Earning Date
- WES 02-26-2025
- ICLR 02-19-2025
- Dividend Yield
- WES 8.42%
- ICLR N/A
- EPS Growth
- WES 44.12
- ICLR 44.49
- EPS
- WES 3.91
- ICLR 8.99
- Revenue
- WES $3,534,928,000.00
- ICLR $8,306,823,000.00
- Revenue This Year
- WES $19.98
- ICLR $3.99
- Revenue Next Year
- WES $2.71
- ICLR $2.19
- P/E Ratio
- WES $10.69
- ICLR $22.50
- Revenue Growth
- WES 16.75
- ICLR 3.63
- 52 Week Low
- WES $27.84
- ICLR $183.38
- 52 Week High
- WES $43.33
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- WES 56.85
- ICLR 42.02
- Support Level
- WES $40.62
- ICLR $194.33
- Resistance Level
- WES $42.38
- ICLR $206.61
- Average True Range (ATR)
- WES 1.08
- ICLR 6.57
- MACD
- WES 0.02
- ICLR -0.48
- Stochastic Oscillator
- WES 59.47
- ICLR 23.27
About WES Western Midstream Partners LP Common Units Representing Limited Partner Interests
Western Midstream Partners LP is a US-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma), North-central Pennsylvania and Texas.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.